Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy.

Damkjær S. et al, (2017), Acta Oncol, 56, 799 - 805

Making progress in early breast cancer: Taking time or accepting risk?

Mannu GS. and Dodwell D., (2017), Eur J Cancer, 78, 24 - 27

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data.

Holyoake DLP. et al, (2017), Radiother Oncol, 123, 431 - 437

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Taylor C. et al, (2017), J Clin Oncol, 35, 1641 - 1649

Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.

Rugbjerg K. et al, (2017), Int J Cancer, 140, 2232 - 2245

Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.

Rehammar JC. et al, (2017), Radiother Oncol, 123, 299 - 305

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

van Nimwegen FA. et al, (2017), Blood, 129, 2257 - 2265

Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).

Bright CJ. et al, (2017), Circulation, 135, 1194 - 1210

Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.

Fidler MM. et al, (2017), Circulation, 135, 951 - 963

A cardiac contouring atlas for radiotherapy.

Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422

Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods

Ntentas G. et al, (2017), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99, E635 - E635

Predicted Cardiac and Second Cancer Risks in Hodgkin Lymphoma Patients Treated With Advanced Proton Beam Therapy Compared to Photon Radiation Therapy

Ntentas G. et al, (2017), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99, S181 - S181

Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.

Henson KE. et al, (2016), Circulation, 134, 1519 - 1531

Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

Ramroth J. et al, (2016), Int J Radiat Oncol Biol Phys, 96, 736 - 747

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Risk Factors Collaborators None., (2016), Lancet, 388, 1659 - 1724

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Mortality and Causes of Death Collaborators None., (2016), Lancet, 388, 1459 - 1544

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators None., (2016), Lancet, 388, 1545 - 1602

Exposure of the Lungs in Breast Cancer Radiation Therapy: A Systematic Review of Lung Doses Published Between 2010 and 2015.

Aznar MC. et al, (2016), Int J Radiat Oncol Biol Phys, 96, E30 - E31

Can Observational Data Replace Randomized Trials?

McGale P. et al, (2016), J Clin Oncol, 34, 3355 - 3357

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.

Wallington M. et al, (2016), Lancet Oncol, 17, 1203 - 1216

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?